TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$119.15 USD
+4.86 (4.25%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $118.87 -0.28 (-0.23%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TMDX 119.15 +4.86(4.25%)
Will TMDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report?
Here's Why TransMedics (TMDX) is a Strong Momentum Stock
Here's Why TransMedics (TMDX) is a Strong Growth Stock
Other News for TMDX
TransMedics Group (TMDX): Evercore ISI Initiates Coverage with 'Outperform' Rating | TMDX Stock News
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls
Apple initiated, Hershey upgraded: Wall Street's top analyst calls
TransMedics Group (TMDX) Has a New Rating from Roth MKM
Crossed Above 20 Day Moving Average appears for TMDX after 0.24% move